Quidel | QDEL - Gross Profit On Sales

Stock Price
11.26
Daily Change
-0.76 -6.32%
Monthly
-26.21%
Yearly
-59.48%
Q2 Forecast
11.34

Quidel reported $274.8M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Agilent USD 946M 44M Dec/2025
Avanos Medical USD 86M 0 Dec/2025
Becton, Dickinson and Co. USD 2.41B 1.72B Dec/2025
Bruker USD 449.2M 69.8M Dec/2025
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Danaher USD 3.59B 375M Mar/2026
Haemonetics USD 202.39M 7.64M Dec/2025
Illumina USD 759M 26M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Merit Medical Systems USD 195.35M 8.94M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
Neogen USD 99M 7.7M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quidel USD 274.8M 1.01B Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
STAAR Surgical USD 43.74M 34.13M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 557.42M 97.44M Dec/2025